Global SNP Genotyping and Analysis Market Overview:

This report studies the Global SNP Genotyping and Analysis Market over the forecast period of 2019 to 2023. The Global SNP Genotyping and Analysis Market is projected to witness an above-average growth over the next couple of years.

According to the market report analysis, Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations that commonly occur in individuals. SNP genotyping has a broad range of applications in a number of industries such as pharmaceuticals, research, agricultural biotechnological and others which leads to change in dairy and meat yield and crop yields. The use of SNP genotyping is growing rapidly from personalized genetic testing to plant and animal biotechnology. SNP genotyping gives an idea about the human genome characterization and transfer of hereditary diseases.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/149475 .

The Global SNP Genotyping and Analysis Market is segmented on the basis of Technology, Application and Region. Based on the Technology, the Global SNP Genotyping and Analysis Market is sub-segmented into SNP Genechips and Microarrays, TaqMan Assay (Allelle-Specific Hybridization), SNP, genotyping based upon Pyrosequencing, SN Plex based upon Applied Biosystems, Sequenom Masarray MALDI-TOF, RFLP (Restricted Fragment Length Polymorphism), SSCP (Single-Strand Conformation Polymorphism), ARMS (Amplication Refractory Mutation System) and others. On the basis of Application, the Global SNP Genotyping and Analysis Market is classified into Pharmaceuticals & Pharmacogenomics, Diagnostic Research, Agricultural Biotechnology, Breeding & Animal Livestock and others.

In terms of the geographic analysis, North America region is considered as most dominant market due to favorable government policies towards proper diagnosis, screening and treatment of fatal diseases, availability of better R&D facilities and the presence of advanced technologies. Europe and APAC market is emerging owing to the development of various plans and policies of government, rising incidences of targeted diseases, improvements in healthcare services, increasing demand for personalized medicines and rising economic development.

Latest Industry Updates:

1 Roche (April 23, 2019) – Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients eligible for targeted therapy – Roche, today announced the launch of the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay for the detection of the HER2 biomarker in breast and gastric cancer. HER2 - human epidermal growth factor receptor 2 - is an important biomarker found in breast and gastric cancers. Its detection and inhibition can help to more effectively manage these aggressive cancers.

The VENTANA HER2 Dual ISH DNA Probe Cocktail assay is designed to be completed within the same day, providing clinicians the ability to get results back quicker than the most common methods of confirmatory testing for HER2. Results can be read using light microscopy, eliminating the need for a specialized fluorescence microscope.

2 Illumina (April 22, 2019) – Illumina and Children’s Hospital of Fudan University in China reached an agreement to conduct rapid whole genome sequencing (rWGS) for critically ill infants in the hospital’s neonatal intensive care unit (NICU). The program is planning to enroll 200 patients to investigate the diagnosis rate of rWGS compared with traditional detection methods. The project will also assess diagnosis time, prognosis improvement and hospitalization turnaround time to provide feasible recommendations for the application of rWGS in the NICU.

Top Leading Key Manufacturers are: Illumina, Roche, Life Technologies Corporation, Sequenom, Affymetrix, Fluidigm and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of SNP Genotyping and Analysis in these regions, from 2013 to 2023 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Purchase this report online with 125 Pages, List of Tables & Figures and in-depth Table of Contents on “Global SNP Genotyping and Analysis Market Report 2019” @ https://www.businessindustryreports.com/buy-now/149475/single .

This study answers to the below key questions:

1 What will the market size be in 2023 and what will the growth rate be?

2 What are the key market trends?

3 What are the challenges to market growth?

4 Who are the key players in this market?

5 What are the market opportunities and threats faced by the key players?

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

[email protected]

+19376349940